MicroRNA-17-92 cluster regulates pancreatic beta-cell proliferation and adaptation

Mol Cell Endocrinol. 2016 Dec 5:437:213-223. doi: 10.1016/j.mce.2016.08.037. Epub 2016 Aug 24.

Abstract

MiR-17-92 cluster contributes to the regulation of mammalian development, aging and tumorigenesis. The functional roles of miR-17-92 in pancreatic beta-cells are largely unknown. In this study, we found that conditional deletion of miR-17-92 in mouse pancreatic beta-cells (miR-17-92βKO) significantly reduces glucose tolerance and the first phase of insulin secretion, despite normal ad libitum fed and fasting glucose levels. Proliferation is down-regulated in pancreatic beta-cells after deleting miR-17-92. MiR-17-92βKO mice show higher phosphatase and tensin homologue (PTEN) and lower phosphorylated AKT in islets. Under high fat diet challenge for 16 weeks, miR-17-92βKO mice lose compensation and exhibit higher glucose levels, and lower insulin secretion. Collectively, these data suggest that miR-17-92 is a critical contributor to molecular mechanisms regulating glucose-stimulated insulin secretion and pancreatic beta-cell adaptation under metabolic stress.

Keywords: Adaptation; MiR-17-92; PTEN; Pancreatic beta-cells; Proliferation.

MeSH terms

  • Adaptation, Physiological*
  • Animals
  • Apoptosis / drug effects
  • Cell Line
  • Cell Proliferation / drug effects
  • Diet, High-Fat
  • Gene Deletion
  • Gene Expression Regulation / drug effects
  • Glucose / pharmacology
  • Glucose Intolerance / genetics
  • Glucose Intolerance / pathology
  • Insulin / metabolism
  • Insulin Secretion
  • Insulin-Secreting Cells / cytology*
  • Insulin-Secreting Cells / drug effects
  • Insulin-Secreting Cells / metabolism*
  • Male
  • Mice, Inbred C57BL
  • Mice, Knockout
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • Phenotype
  • Signal Transduction / drug effects

Substances

  • Insulin
  • MIRN17-92 microRNA, mouse
  • MicroRNAs
  • Glucose